Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal translocations in leukaemia

C E Gauwerky1, C M Croce

  • 1Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107.

Seminars in Cancer Biology
|December 1, 1993
PubMed
Summary

Chromosomal translocations in hematologic malignancies, like Burkitt's lymphoma, drive tumor development by deregulating oncogenes such as c-myc. Understanding these genetic changes aids in diagnosing and developing targeted therapies for leukemias and lymphomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7.

The Journal of biological chemistry·2001
Same author

Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.

Cancer research·2001
Same author

Fez1/lzts1 alterations in gastric carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Same author

Cervical dysplasia, ploidy, and human papillomavirus status correlate with loss of Fhit expression.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Area of Science:

  • Hematologic Oncology
  • Cancer Genetics
  • Molecular Pathology

Background:

  • Chromosomal translocations are key drivers in many hematologic malignancies.
  • The t(8;14) translocation in Burkitt's lymphoma exemplifies oncogene deregulation.
  • Overexpressed c-myc and altered oncogenes (e.g., c-abl, ALL-1) are implicated in various leukemias and lymphomas.

Purpose of the Study:

  • To elucidate the role of chromosomal translocations in the pathogenesis of hematologic malignancies.
  • To highlight molecular mechanisms of oncogene activation in cancers like Burkitt's lymphoma and leukemia.
  • To underscore the diagnostic and therapeutic potential of understanding these genetic alterations.

Main Methods:

  • Molecular characterization of chromosomal translocations.
  • Somatic cell genetic studies.
  • Analysis of oncogene deregulation and fusion events.

Main Results:

  • Demonstrated c-myc oncogene deregulation by immunoglobulin heavy chain enhancers in Burkitt's lymphoma.
  • Identified specific translocations and gene fusions in various leukemias (CML, t(4;11)).
  • Linked cytogenetic changes to tumor progression and aggressive phenotypes.

Conclusions:

  • Molecular and genetic studies have significantly advanced the understanding of leukemia and lymphoma etiology and progression.
  • These findings have direct applications in clinical diagnostics.
  • Future therapies can be designed based on a molecular understanding of these malignancies.

Related Experiment Videos